Big Biology is Here to Stay

Why R01-funded biologists should throw their support behind large-scale research projects.

Written bySteven Wiley
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One of the favorite complaints of biologists is that we spend too much money on large-scale research projects. Grousing about big science, however, is nothing new. I remember in the early 1990s when the NIH announced its intention to sequence the human genome. NIH funding was tight at the time, and the idea of throwing scarce resources at a project of dubious feasibility, and without a clear scientific objective, seemed ludicrous. Many of my university colleagues wrote protest letters to stop the perceived boondoggle, to no avail. I personally thought it was a waste of money. We were all wrong.

The success of the Human Genome Project, in part, helped convinced the public that biologists' work was worthy of more public funds, and it helped justify the doubling of the NIH budget. It also started a push towards big science at the NIH, exemplified by the "Roadmap" initiative, started in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies